Baxalta Now Part Of Shire
Clinical trials sponsored by Baxalta Now Part Of Shire, explained in plain language.
-
Hemophilia a drug ADYNOVI under Long-Term safety review
Disease control OngoingThis study monitors 207 people with hemophilia A who are taking ADYNOVI/ADYNOVATE as part of their regular care. The goal is to track any long-term side effects, including problems with kidneys, liver, or nerves. It does not test if the drug works, but rather how safe it is over …
Sponsor: Baxalta now part of Shire • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
One-Time gene shot could tame hemophilia b bleeding
Disease control OngoingThis study tests a single intravenous dose of gene therapy (AskBio009) in up to 30 adults with hemophilia B, a bleeding disorder. The therapy delivers a working copy of the factor IX gene to help the body produce its own clotting factor. The goal is to reduce the frequency and se…
Phase: PHASE1, PHASE2 • Sponsor: Baxalta now part of Shire • Aim: Disease control
Last updated May 04, 2026 16:30 UTC